Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RVTYthis companyRevvity, Inc.	$157.32	46.69×	1.52×	3.85×	17.75×	-25.0%	53.1%	12.5%	8.5%	3.3%	2.8%	4.6%	0.48×	3.39×	3.87×	1.68×	0.3%	8	3.34	3	B-
AAgilent Technologies, Inc.	$176.74	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
BIOBio-Rad Laboratories, Inc.	$386.07	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
CRLCharles River Laboratories International, Inc.	$350.93	-69.99×	3.19×	2.51×	31.51×	-76.6%	30.5%	12.6%	-3.6%	-4.6%	8.4%	5.1%	0.97×	6.94×	4.74×	1.29×	0.0%	5	2.99	1	C-
DHRDanaher Corporation	$230.96	45.15×	3.08×	6.59×	25.3×	-14.1%	60.9%	20.9%	14.7%	6.9%	5.7%	3.2%	0.35×	1.99×	19.38×	1.87×	0.5%	7	3.74	3	B
MLABMesa Laboratories, Inc.	$131.87	72.48×	2.62×	1.96×	17.84×	-93.2%	63.5%	7.4%	2.7%	3.6%	2.8%	8.1%	0.91×	4.02×	1.73×	1.72×	0.7%	7	2.05	2	B-
Peer median	—	31.89×	3.08×	3.2×	23.43×	-76.6%	52.4%	12.6%	14.7%	6.9%	5.7%	4.5%	0.5×	1.99×	5.52×	1.87×	0.5%	7	3.65	3	—